Huawei rises from the dead, outsells iPhone in China

Sanctions crushed Huawei for a time, but new Counterpoint data says Huawei is back.

The Huawei Mate 60 Pro+. It's a phone made without most of the traditional US-allied suppliers.

Enlarge / The Huawei Mate 60 Pro+. It's a phone made without most of the traditional US-allied suppliers. (credit: Huawei)

Counterpoint Research has an interesting new report on the return of Huawei in China. Market share for the Chinese government's favorite tech company has shot up 64 percent for the first six weeks of 2024. Counterpoint says this is thanks to "continued demand for Huawei’s Mate 60 series," Huawei's first big smartphone release in its US-sanctions comeback tour.

Counterpoint says the market share for the major US incumbent, Apple, has plummeted 24 percent in 2024, allowing Huawei's 17 percent market share to beat Apple's 16 percent. For the early days of the year, Huawei is now the No. 2 smartphone manufacturer in China, Vivo is No. 1, and Apple is tied for third with Honor, a Huawei offshoot. I bet the Chinese government is thrilled.

Huawei was supposed to be dead! For a time, the company was crushed by US sanctions, which really kicked in around 2021. The company mostly retracted to China-only distribution and lost most of its market share thanks to dwindling chip supplies. A few years later, Huawei is getting its homegrown ecosystem back in gear, enough to release the Mate 60 Pro, the company's post-sanctions flagship.

Read 4 remaining paragraphs | Comments

Big Pharma is “coming to the table” on price negotiations as it loses in court

Negotiating prices is not a “gun to the head,” judge rules.

Big Pharma is “coming to the table” on price negotiations as it loses in court

Enlarge (credit: Getty | Bodo Marks)

Federal health officials this week trumpeted progress in negotiating lower Medicare drug prices as big pharmaceutical companies faced another legal loss in their efforts to have the negotiations ruled unconstitutional.

This week, the Department of Health and Human Services announced that it had received the first counteroffers from pharmaceutical makers for all 10 drugs up for price negotiation. The negotiations—a provision in the Inflation Reduction Act of 2022—kicked off late last year with the Centers for Medicare and Medicaid Services (CMS) announcing the 10 drugs selected for bargaining. Those 10 drugs have seen significant price hikes over recent years and, combined, cost Medicare $50.5 billion in gross during 2022, with an additional $3.4 billion in out-of-pocket costs for patients. The health department sent its opening pricing offers to drug makers on February 1.

"We are committed to constructive dialogue and are glad the drug companies are coming to the table," HHS Secretary Xavier Becerra said in a statement. "These are good-faith, up front negotiations," he said, which will "keep money in the pockets of millions of Americans instead of Big Pharma."

Read 12 remaining paragraphs | Comments

Big Pharma is “coming to the table” on price negotiations as it loses in court

Negotiating prices is not a “gun to the head,” judge rules.

Big Pharma is “coming to the table” on price negotiations as it loses in court

Enlarge (credit: Getty | Bodo Marks)

Federal health officials this week trumpeted progress in negotiating lower Medicare drug prices as big pharmaceutical companies faced another legal loss in their efforts to have the negotiations ruled unconstitutional.

This week, the Department of Health and Human Services announced that it had received the first counteroffers from pharmaceutical makers for all 10 drugs up for price negotiation. The negotiations—a provision in the Inflation Reduction Act of 2022—kicked off late last year with the Centers for Medicare and Medicaid Services (CMS) announcing the 10 drugs selected for bargaining. Those 10 drugs have seen significant price hikes over recent years and, combined, cost Medicare $50.5 billion in gross during 2022, with an additional $3.4 billion in out-of-pocket costs for patients. The health department sent its opening pricing offers to drug makers on February 1.

"We are committed to constructive dialogue and are glad the drug companies are coming to the table," HHS Secretary Xavier Becerra said in a statement. "These are good-faith, up front negotiations," he said, which will "keep money in the pockets of millions of Americans instead of Big Pharma."

Read 12 remaining paragraphs | Comments

X Partially Defeats Music Piracy Liability Claims in Nashville Federal Court

The federal court in Nashville has handed an early and partial win to Elon Musk’s X as it fights back against a copyright complaint filed by several record labels. Judge Trauger dismissed the labels’ direct and vicarious copyright infringement claims but left the contributory infringement claims intact. This means that X can still be held liable for failing to act properly against repeat copyright infringers.

From: TF, for the latest news on copyright battles, piracy and more.

xUnder U.S. law, online service providers must respond to takedown notices and implement a meaningful policy to terminate the accounts of repeat infringers.

Many of the large social media platforms stick to these rules but, according to a lawsuit filed by several prominent music companies last year, X is not among them.

In a lawsuit filed at a federal court in Nashville last summer, Universal Music, Sony Music, EMI, and others accused X Corp of “breeding” mass copyright infringement. The labels argued that X, formerly Twitter, failed to respond adequately to takedown notices and lacked a proper termination policy.

“Twitter fuels its business with countless infringing copies of musical compositions, violating Publishers’ and others’ exclusive rights under copyright law,” the complaint alleged.

Elon Musk himself had previously added fuel to the smoldering fire, characterizing the Digital Millennium Copyright Act (DMCA) as a “plague on humanity”.

Motion to Dismiss

Musk’s company was swift to respond to the allegations with a request for the Court to dismiss all copyright infringement claims. According to X, the record labels failed to show how the company or its employees actively contributed to any piracy that allegedly took place on the platform.

After taking in the arguments from both sides, Nashville District Court Judge Aleta Trauger responded to the request as follows.

“It does not appear to be disputed, in this litigation, that X/Twitter users sometimes engage in copyright infringement. What is disputed is the extent to which X Corp. has actively encouraged that conduct, if at all,” Judge Trauger writes.

The labels alleged three different claims in their complaint: direct copyright infringement, vicarious copyright infringement, and contributory copyright infringement. X asked for all to be dismissed and the Court partially agreed.

Direct Infringement: Dismissed

The record labels’ direct infringement claim largely relies on the Copyright Act’s “Transmit Clause”, suggesting that X is liable because it directly engages in the public performance of pirated music.

This allegation relies heavily on the Aereo case, where the operators of the ‘time-shifting’ service were found to be direct infringers for transmitting over-the-air TV signals to their subscribers.

In the present case, X also transmits copyright-infringing material. However, following a lengthy semantic consideration, Judge Trauger concludes that various nuanced meanings can be applied to the term ‘transmission’.

For example, if person Y sends a pirated file to person Z, they are transmitting that file. At the same time, their ISPs are also transmitting the file, as are the backbone Internet services, and cable owners. Not all of these parties are necessarily ‘direct’ infringers.

Judge Trauger says that Aereo’s exclusive purpose was to transmit copyrighted signals but the same can’t be said for X, which has a multitude of other purposes. As such, the Court doesn’t believe that the “transmit clause” applies here.

“As the Supreme Court explained in Aereo, the Transmit Clause was adopted with the specific purpose of ensuring that both the ‘broadcaster’ and the ‘viewer’ of an audiovisual work could, where appropriate, be held liable for direct infringement of the type involved in the transmission of broadcast television through cable systems.

“That purpose is consistent with the conclusion that ‘transmission’ refers to the actions of the sender and/or ultimate recipient of a copyright-protected work—not those of the operators of the channels through which that transmission was accomplished,” Judge Trauger adds.

The Court stresses that claims against third parties are possible under theories of secondary liability, but not under direct infringement. Therefore, the first claim is dismissed.

Vicarious Infringement: Dismissed

An example of a secondary liability claim is vicarious copyright infringement. In the complaint, the music companies alleged that X is vicariously liable because it profited from its users’ pirating activities while failing to put an end to them.

Judge Trauger doesn’t rule out that X turned a blind eye to piracy, which may or may not have acted as a draw to other pirates. However, to establish vicarious infringement the accused party needs to have some type of formal control over the infringer. That doesn’t apply here, she concludes.

“X Corp. undoubtedly had some power over X/Twitter’s users—the way that a company that provides a valued service always has power over the customers who rely on it — but that does not turn customers into even loose equivalents of agents or subordinates,” Judge Trauger writes.

As such, the vicarious copyright infringement claim is also dismissed. However, similar ‘piracy-supporting’ allegations can still be brought up as part of the contributory infringement claim.

Contributory Infringement: Mixed

In analyzing the contributory infringement claim, the Nashville court must consider whether X “induces, causes, or materially contributes to the infringing conduct” of its users.

The music companies believe so, as X made it very easy to upload infringing material and monetized pirated content on its platform. However, Judge Trauger notes that these allegations apply to everything on the platform, not just pirated material.

“Any feature that makes a service easier for all of its users will, by definition, also make the service easier for bad actors. The plaintiffs have not identified any basis for concluding that X Corp. was obligated to make its service worse for everyone, just to punish the people who misuse it,” Judge Trauger notes.

The Court therefore rejects the notion that X is contributorily liable in the general sense. However, there are specific allegations that survive the motion to dismiss.

“Particularly striking is the allegation that X Corp. enforces its copyright policies less stringently against individuals willing to pay for its ‘verified’ service,” the Judge writes.

“Similarly, if X Corp. engaged in egregious delays in responding to valid takedown notices, or outright ignored some notices that were both facially and actually valid, that could support liability.”

Finally, Judge Trauger will also leave the ‘repeat infringer’ allegations intact. If the music companies can effectively prove that X willingly turned a blind eye to pirating users, that could make the company liable.

“Again, there is no basis in the law for concluding that the operator of a social media platform will face liability simply because it was less draconian in its enforcement than copyright holders would prefer.

“If, however, there was a class of X/Twitter users who were brazenly using the platform as an infringement tool, and X Corp. made the decision to unreasonably withhold enforcement of its own policies against those users, with the foreseeable consequence of ongoing infringement, then X Corp. could plausibly be held contributorily liable.”

The Court’s decision is a mixed bag. While X managed to get most claims dismissed, the music companies can still pursue their claim for contributory copyright infringement. While that is yet to be proven in court, millions of dollars in damages are still on the line.

A copy of Judge Trauger’s memorandum, detailing the decision in response to the motion to dismiss, is available here (pdf)

partial dismiss

From: TF, for the latest news on copyright battles, piracy and more.

Producing more but understanding less: The risks of AI for scientific research

A psychologist and an anthropologist ponder the epistemic risks AI could pose for science.

3d illustration of brain with wires

Enlarge / Current concerns about AI tend to focus on its obvious errors. But psychologist Molly Crockett and anthropologist Lisa Messeri argue that AI also poses potential long-term epistemic risks to the practice of science. (credit: Just_Super/E+ via Getty)

Last month, we witnessed the viral sensation of several egregiously bad AI-generated figures published in a peer-reviewed article in Frontiers, a reputable scientific journal. Scientists on social media expressed equal parts shock and ridicule at the images, one of which featured a rat with grotesquely large and bizarre genitals.

As Ars Senior Health Reporter Beth Mole reported, looking closer only revealed more flaws, including the labels "dissilced," "Stemm cells," "iollotte sserotgomar," and "dck." Figure 2 was less graphic but equally mangled, rife with nonsense text and baffling images. Ditto for Figure 3, a collage of small circular images densely annotated with gibberish.

The paper has since been retracted, but that eye-popping rat penis image will remain indelibly imprinted on our collective consciousness. The incident reinforces a growing concern that the increasing use of AI will make published scientific research less trustworthy, even as it increases productivity. While the proliferation of errors is a valid concern, especially in the early days of AI tools like ChatGPT, two researchers argue in a new perspective published in the journal Nature that AI also poses potential long-term epistemic risks to the practice of science.

Read 47 remaining paragraphs | Comments

Producing more but understanding less: The risks of AI for scientific research

A psychologist and an anthropologist ponder the epistemic risks AI could pose for science.

3d illustration of brain with wires

Enlarge / Current concerns about AI tend to focus on its obvious errors. But psychologist Molly Crockett and anthropologist Lisa Messeri argue that AI also poses potential long-term epistemic risks to the practice of science. (credit: Just_Super/E+ via Getty)

Last month, we witnessed the viral sensation of several egregiously bad AI-generated figures published in a peer-reviewed article in Frontiers, a reputable scientific journal. Scientists on social media expressed equal parts shock and ridicule at the images, one of which featured a rat with grotesquely large and bizarre genitals.

As Ars Senior Health Reporter Beth Mole reported, looking closer only revealed more flaws, including the labels "dissilced," "Stemm cells," "iollotte sserotgomar," and "dck." Figure 2 was less graphic but equally mangled, rife with nonsense text and baffling images. Ditto for Figure 3, a collage of small circular images densely annotated with gibberish.

The paper has since been retracted, but that eye-popping rat penis image will remain indelibly imprinted on our collective consciousness. The incident reinforces a growing concern that the increasing use of AI will make published scientific research less trustworthy, even as it increases productivity. While the proliferation of errors is a valid concern, especially in the early days of AI tools like ChatGPT, two researchers argue in a new perspective published in the journal Nature that AI also poses potential long-term epistemic risks to the practice of science.

Read 47 remaining paragraphs | Comments

Company that plans to bring back the mammoth takes a key step

Making elephant stem cells required an elaborate process, lots of failures.

Large collection of cells with a red outline and white nucleus.

Enlarge / Elephant stem cells turned out to be a hassle to generate. (credit: Colossal.)

A company called Colossal plans on pioneering the de-extinction business, taking species that have died within the past few thousand years and restoring them through the use of DNA editing and stem cells. It's grabbed headlines recently by announcing some compelling targets: the thylacine, an extinct marsupial predator, and an icon of human carelessness, the dodo. But the company was formed to tackle an even more audacious target: the mammoth, which hasn't roamed the northern hemisphere for thousands of years.

Obviously, there are a host of ethical and conservation issues that would need to be worked out before Colossal's plans go forward. But there are some major practical hurdles as well, most of them the product of the distinct and extremely slow reproductive biology of the mammoth's closest living relatives, the elephants. At least one of those has now been cleared, as the company is announcing the production of the first elephant stem cells. The process turned out to be extremely difficult, suggesting that the company still has a long road ahead of it.

Lots of hurdles

Colossal's basic road map for de-extinction is pretty straightforward. We have already obtained the genomes of a number of species that have gone extinct recently, as well as those of their closest living relatives. By comparing the two, we can identify key genetic differences that make the extinct species distinct. We can then edit those differences into stem cells obtained from the living species and use that species as a surrogate for embryos produced from these stem cells. This will have to be done using stem cells from a number of individuals to ensure that the resulting population has sufficient genetic diversity to be stable.

Read 17 remaining paragraphs | Comments

Company that plans to bring back the mammoth takes a key step

Making elephant stem cells required an elaborate process, lots of failures.

Large collection of cells with a red outline and white nucleus.

Enlarge / Elephant stem cells turned out to be a hassle to generate. (credit: Colossal.)

A company called Colossal plans on pioneering the de-extinction business, taking species that have died within the past few thousand years and restoring them through the use of DNA editing and stem cells. It's grabbed headlines recently by announcing some compelling targets: the thylacine, an extinct marsupial predator, and an icon of human carelessness, the dodo. But the company was formed to tackle an even more audacious target: the mammoth, which hasn't roamed the northern hemisphere for thousands of years.

Obviously, there are a host of ethical and conservation issues that would need to be worked out before Colossal's plans go forward. But there are some major practical hurdles as well, most of them the product of the distinct and extremely slow reproductive biology of the mammoth's closest living relatives, the elephants. At least one of those has now been cleared, as the company is announcing the production of the first elephant stem cells. The process turned out to be extremely difficult, suggesting that the company still has a long road ahead of it.

Lots of hurdles

Colossal's basic road map for de-extinction is pretty straightforward. We have already obtained the genomes of a number of species that have gone extinct recently, as well as those of their closest living relatives. By comparing the two, we can identify key genetic differences that make the extinct species distinct. We can then edit those differences into stem cells obtained from the living species and use that species as a surrogate for embryos produced from these stem cells. This will have to be done using stem cells from a number of individuals to ensure that the resulting population has sufficient genetic diversity to be stable.

Read 17 remaining paragraphs | Comments

OpenAI responds to Elon Musk lawsuit by clarifying its “open“ nature

“The open in OpenAI means that everyone should benefit from the fruits of AI after it’s built.”

The OpenAI logo as an opening to a red brick wall.

Enlarge (credit: Benj Edwards / Getty Images)

On Tuesday, OpenAI published a blog post titled "OpenAI and Elon Musk" in response to a lawsuit Musk filed last week. The ChatGPT maker shared several archived emails from Musk that suggest he once supported a pivot away from open source practices in the company's quest to develop artificial general intelligence (AGI). The selected emails also imply that the "open" in "OpenAI" means that the ultimate result of its research into AGI should be open to everyone but not necessarily "open source" along the way.

In one telling exchange from January 2016 shared by the company, OpenAI Chief Scientist Illya Sutskever wrote, "As we get closer to building AI, it will make sense to start being less open. The Open in openAI means that everyone should benefit from the fruits of AI after it's built, but it's totally OK to not share the science (even though sharing everything is definitely the right strategy in the short and possibly medium term for recruitment purposes)."

In response, Musk replied simply, "Yup."

Read 8 remaining paragraphs | Comments

OpenAI responds to Elon Musk lawsuit by clarifying its “open“ nature

“The open in OpenAI means that everyone should benefit from the fruits of AI after it’s built.”

The OpenAI logo as an opening to a red brick wall.

Enlarge (credit: Benj Edwards / Getty Images)

On Tuesday, OpenAI published a blog post titled "OpenAI and Elon Musk" in response to a lawsuit Musk filed last week. The ChatGPT maker shared several archived emails from Musk that suggest he once supported a pivot away from open source practices in the company's quest to develop artificial general intelligence (AGI). The selected emails also imply that the "open" in "OpenAI" means that the ultimate result of its research into AGI should be open to everyone but not necessarily "open source" along the way.

In one telling exchange from January 2016 shared by the company, OpenAI Chief Scientist Illya Sutskever wrote, "As we get closer to building AI, it will make sense to start being less open. The Open in openAI means that everyone should benefit from the fruits of AI after it's built, but it's totally OK to not share the science (even though sharing everything is definitely the right strategy in the short and possibly medium term for recruitment purposes)."

In response, Musk replied simply, "Yup."

Read 8 remaining paragraphs | Comments